Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studies.

作者: Hildegard Spahn-Langguth , Gabriele Hahn , Ernst Mutschler , Werner Möhrke , Peter Langguth

DOI: 10.1016/0378-4347(92)80580-J

关键词: Detection limitDerivatizationTranylcypromine SulfateHigh-performance liquid chromatographyTranylcypromineChemistryFluorescence spectrometryChromatographyElutionEnantiomer

摘要: In order to be able measure low concentrations of tranylcypromine enantiomers in biological material, chiral fluorescent derivatization and high-performance liquid chromatography (HPLC) were employed. The internal standard S-(+)-amphetamine borate-sodium hydroxide buffer pH 11 added plasma or urine sample aliquots. o-Phthaldialdehyde was used for precolumn combination with the mercaptan N-acetylcysteine. HPLC resolution diastereoisomeric derivatives possible on an octadecylsilane column. mobile phase consisted sodium phosphate solution 6.5, methanol tetrahydrofuran. fluorescence eluate monitored at 344/442 nm. intra-day coefficients variation below 10%, limit determination 0.5 ng/ml. assay found applicable routine analyses a preliminary pharmacokinetic study, which oral dose 20 mg racemic sulfate administered three healthy volunteers. generally low, those S-(-)-tranylcypromine significantly exceeded R-(+)-enantiomer. Average maximum 57.5 6.3 ng/ml S- R-tranylcypromine, respectively. While S-tranylcypromine well detectable within whole study period (8 h), R-tranylcypromine fell detection after 4 h two out studied

参考文章(14)
Mallinger Ag, Thase Me, Edwards Dj, Knopf S, Himmelhoch Jm, Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions. Journal of Clinical Psychopharmacology. ,vol. 10, pp. 176- 183 ,(1990)
Alan G Mallinger, David J Edwards, Jonathan M Himmelhoch, Steven Knopf, Joan Ehler, Pharmacokinetics of tranylcypromine in patients who are depressed: relationship to cardiovascular effects. Clinical Pharmacology & Therapeutics. ,vol. 40, pp. 444- 450 ,(1986) , 10.1038/CLPT.1986.205
Leslie Z. Benet, Renato L. Galeazzi, Noncompartmental Determination of the Steady‐State Volume of Distribution Journal of Pharmaceutical Sciences. ,vol. 68, pp. 1071- 1074 ,(1979) , 10.1002/JPS.2600680845
G. B. Baker, D. R. Hampson, R. T. Courts, R. G. Micetich, T. W. Hall, T. S. Rao, Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine. Journal of Neural Transmission. ,vol. 65, pp. 233- 243 ,(1986) , 10.1007/BF01249085
GP Reynolds, WD Rausch, P. Riederer, Effects of tranylcypromine stereoisomers on monamine oxidation in man. British Journal of Clinical Pharmacology. ,vol. 9, pp. 521- 523 ,(1980) , 10.1111/J.1365-2125.1980.TB05852.X
Hitoshi Nohta, Kiyoshi Zaitsu, Yasuto Tsuruta, Yosuke Ohkura, Fluorimetric assay for monoamine oxidases A and B by means of p-sulfamoylbenzylamine and benzylamine Analytica Chimica Acta. ,vol. 156, pp. 253- 261 ,(1984) , 10.1016/S0003-2670(00)85556-7
Heidrun Weber, Hildegard Spahn, E. Mutschler, W. Möhrke, Activated α-alkyl-α-arylacetic acid enantiomers for stereoselective thin-layer chromatographic and high-performance liquid chromatographic determination of chiral amines Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 307, pp. 145- 153 ,(1984) , 10.1016/S0378-4347(00)84081-5